WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

WhiteOak Capital Pharma and Healthcare Fund-Reg (G) - Portfolio Analysis

Portfolio Overview

As of October 31, 2025

Asset Allocation

Equity: 90.89%Others: 9.11%

Market Cap

Large Cap: 18.88%Small Cap: 46.07%Mid Cap: 23.96%Equity: 1.98%

Number of stocks

60

Top 10 Holdings

99.18% of portfolio

Market Cap of Equity

Large Cap
18.8760%
Small Cap
46.0656%
Mid Cap
23.9602%
Equity
1.9843%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd15.63%
Divi's Laboratories Ltd13.73%
J.B. Chemicals & Pharmaceuticals Ltd12.97%
Fortis Healthcare Ltd12.64%
Laurus Labs Ltd9.36%
Cipla Ltd8.39%
Neuland Laboratories Ltd7.65%
Lupin Ltd7.46%
Sai Life Sciences Ltd5.89%
Krishna Institute of Medical Sciences Ltd5.46%

Sector Allocation of Equity

Healthcare87.71%
Basic Materials3.18%
Financial Services0.00%

SIP Amount

Monthly SIP Date

WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.